|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
The rise of antibody pharmaceuticals and their future
If you have a question about this talk, please contact Phil Brereton.
Sir Greg Winter, Ph.D., FRS , (Master, Trinity College, University of Cambridge) is a British biochemist and a pioneer of therapeutic monoclonal antibodies who invented techniques to humanise antibodies using phage display for therapeutic uses. He founded Cambridge Antibody Technology (acquired by Astrazeneca in 2006 for £702m) and Bicycle Therapeutics and is on the Scientific Advisory Board of Covagen.
This talk is part of the Cambridge Science Summer School 2012 series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsApplied and Computational Analysis Graduate Seminar Number theory study group: Iwasawa theory Lees Knowles Lectures : Total War : The Soviet Union and the Eastern Front in a Comparative Framework
Other talksNeedles in a haystack: Tracking down the genetic cause of rare diseases. Geometric Mechanics & Symmetry: From Finite to Infinite Dimensions short course - day 2 An analytic approach to minimise the grand potential functional in statistical mechanics Title TBC. Subject area: spinal cord injury Constructions of Authority in 14th Century Morocco: The Material Argument for Marinid Rule Hydrodynamic description of thin nematic films